SS
BCDA icon

SBI Securities’s BioCardia BCDA Stock Holding History

SBI Securities’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11 Hold
9
– – ﹤0.01% 3918
2026
Q1 		$11 Buy
9
+3
+50% +$4 ﹤0.01% 3837
2025
Q4 		$8 Sell
6
-1
-14% -$1 ﹤0.01% 3889
2025
Q3 		$9 Buy
7
+1
+17% +$2 ﹤0.01% 4038
2025
Q2 		$12 Sell
6
-2
-25% -$4 ﹤0.01% 3981
2025
Q1 		$20 Sell
8
-7
-47% -$17 ﹤0.01% 3852
2024
Q4 		$33 Buy
+15
New +$35 ﹤0.01% 3723

Other funds holding BCDA

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PP
Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SBI Securities's BCDA Position: Q2 2026 in Review

SBI Securities held its BioCardia (BCDA) position steady in Q2 2026 at 9 shares worth $11. The position accounts for ﹤0.01% of the portfolio, ranked #3918.

SBI Securities first reported a position in BCDA in Q4 2024 and has held it in 7 quarters since. The position peaked at $33 in Q4 2024. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • SBI Securities held 9 shares of BioCardia worth $11 as of Q2 2026.
  • SBI Securities left its BioCardia share count unchanged in Q2 2026.
  • BioCardia made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3918 holding.
  • SBI Securities first reported a position in BioCardia in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's BioCardia position peaked at $33 in Q4 2024.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.